Helen Floersh

Staff Reporter (Healthcare, Law, Biotech)

Helen covers healthcare, law, insurance and biotechnology in the greater Valley region.

Email: hfloersh@sfvbj.com
Phone: 818-316-3121 Extension: 112

Recent Stories

MannKind Pays Down Debt With Shares

MannKind Corp. in Westlake Village has issued 7.3 million shares to creditor Deerfield to pay down $7 million in debt, according to Securities and Exchange documents filed Friday.

Cure Pharmaceutical Buys Therapix Assets

Cure Pharmaceutical in Oxnard announced Wednesday that it has signed a term agreement for the acquisition of the non-pain assets of Therapix Biosciences Ltd., a clinical-stage pharmaceutical company that is developing cannabinoid-based medications.

Simulations Plus Beats Wall St. on Revenue

Simulations Plus Inc. reported on Tuesday profits of $2.4 million for its third fiscal quarter.

Bar Association Re-Opens Mediation Center

COURTS: Judges can refer cases to Tarzana service for low-cost resolution.

Bar Association opens mediation center.

Women Owners Emphasize Career-Long Learning

LIST: Seminars, classes, mentorships and webinars develop leadership style.

Female entrepreneurs discuss leadership styles.

Conejo’s Biotech Cluster

Atara Biotherapeutics opens ATOM center in Thousand Oaks

Atara Biotherapeutics adds to its Conejo Valley presence with new building.

Preview: Conejo's Biotech Cluster

Atara Biotherapeutics opens ATOM center in Thousand Oaks.

Amgen Sues Competitor Over Sensipar Generic

Amgen Inc. in Thousand Oaks has filed a lawsuit against drugmaker Intas Pharmaceuticals Inc. and its subsidiary Accord Healthcare Inc. over its plans to manufacture a generic of Amgen’s medication Sensipar.

BlackLine Bolsters its Asia-Pacific Presence

Blackline Inc. in Woodland Hills has announced the appointment of an executive to oversee the company’s expansion into the Asia-Pacific region.

City Council Urges Kaiser to Keep NoHo Jobs

The Los Angeles. City Council has unanimously passed a resolution urging Kaiser Permanente not to cut 306 jobs in Los Angeles, including 34 positions at a laboratory in North Hollywood.

More stories >>